Highlights Vectus Biosystems Limited

Equities

VBS

AU000000VBS9

Market Closed - Australian S.E. Other stock markets 01:08:56 2024-05-28 EDT			5-day change	1st Jan Change
0.13 ^AUD	-.--%		-.--%	-56.67%

05-23	Vectus Biosystems Appoints CTO	MT
05-20	Vectus Biosystems CEO Passes Away	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vectus Biosystems Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-23	CI
Vectus Biosystems Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Vectus Biosystems Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-24	CI
Vectus Biosystems Limited Announces Completion of Phase Ia for VB0004	22-09-13	CI
Vectus Biosystems Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-31	CI
Vectus Biosystems Limited Announces Completion of Second M.A.D. Study for Vb0004	22-08-07	CI
Vectus Biosystems Limited Announces Completion of Final Single Ascending Dose Study and First Multiple Ascending Dose Study for VB0004	22-05-24	CI
Vectus Biosystems : Half Yearly Report and Appendix 4D	22-02-25	PU
Vectus Biosystems Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-25	CI
Vectus Biosystems Limited Announces Fourth of the Five Planned Cohorts in the Single Ascending Dose Segment of Its First-In-Human Tria	22-02-20	CI
Vectus Biosystems Limited Announces Third S.A.D. Group Reviewed by Trial Safety Review Committee	21-11-28	CI
Vectus Biosystems Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-31	CI
Vectus Biosystems Limited Announces Successful Completion of First Group in Phase I Human Trial	21-08-22	CI
Vectus Biosystems : HREC Approves Vectus Biosystems' Phase One Human Trial for Hypertension Drug in Australia; Shares Surge 30%	21-06-16	MT
Approval Receives Approval from the Human Research Ethics Committee for Phase I Trial in Australia	21-06-16	CI
Vectus Biosystems Limited Reports Earnings Results for the Half Year Ended December 31, 2020	21-02-26	CI
Vectus Biosystems Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-08-31	CI
Vectus Biosystems Limited Reports Earnings Results for the Half Year Ended December 31, 2019	20-02-28	CI
Vectus Biosystems Limited Announces Publication of Preclinical Data in Model of Cardiac Fibrosis	19-10-07	CI
Vectus Biosystems Limited Reports Earnings Results for the Full Year Ended June 30, 2019	19-08-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Vectus Biosystems Limited

Equities

VBS

AU000000VBS9

Highlights

Filters